REFERENCES
Davis GL, Balart LA, Schiff ER, Lindsay K, Bodenheimer HC Jr, Perrillo RP, CareyW, Jacobson IM, Payne J, Dienstag JL, Van Thiel DH, Tamburro C, Lefkowitch J, Albrecht J, Meschievitz C, Ortego TJ, Gibas A, Hepatitis Interventional Therapy Group: Treatment of chronic hepatitis C with recombinant interferon alpha N Engl J Med 321:1501-1506, 1989
Teragawa H, Hondo T, Takahashi K, Watanabe H, Ohe H, Hattori N, Watanabe Y, Amano H, Hino F, Ohbayashi M, Urushihara T, Yonehara S: Sarcoidosis after interferon therapy for chronic active hepatitis C. Intern Med 35:19-23, 1996
Nakajima M, Kubota Y, Miyashita N, Niki Y, Matsushima T, Manabe T: Recurrence of sarcoidosis following interferon alpha therapy for chronic hepatitis C. Intern Med 35:376-379, 1996
Hoffmann RM, Jung MC, Motz R, Gossl C, Emslander HP, Zachoval R, Pape GR: Sarcoidosis associated with interferon-alpha therapy for chronic hepatitis C. J Hepatol; 28:1058-1063, 1998
Chin K, Tabata C, Sataka N, Nagai S, Moriyasu F, Kuno K: Pneumonitis associated with natural and recombinant interferon alfa therapy for chronic hepatitis C. Chest 105:939-941, 1994
Yufu Y, Yamashita S, Nishimura J, Nawata H, Hirata J: Interstitial pneumonia caused by interferon-alpha in chronic myelogenous leukemia. Am J Hematol 47:253, 1994
Vander Els NJ, Gerdes H: Sarcoidosis and IFN-alpha treatment. Chest 117:294, 2000.
Berlein-Konig BE, Hein R, Abeck D, Eengst R, Ring J: Cutaneous sarcoid foreign body granulomas developing in sites of previous skin injury after systemic interferon-alpha treatment for chronic hepatitis C. Br J Dermatol 140:370-372, 1999
Schmuth M, Prior C, Illersperger B, Topar G, Fritsch P, Sepp N: Systemic sarcoidosis and cutaneous lymphoma: is the association fortuitous? Br J Dermatol 140:952-955, 1999
Pietropaoli A, Modrak J, Utell M: Interferon-alpha therapy associated with the development of sarcoidosis. Chest 116:569-572, 1999
Pinkston P, Bitterman PB, Crystal RG: Spontaneous release of interleukin-2 by lung T lymphocytes in active pulmonary sarcoidosis. N Engl J Med 308:793-800, 1983
Robinson BW, McLemore TL, Crystal RG: Gamma interferon is spontaneously released by alveolar macrophages and lung T lymphocytes in patients with pulmonary sarcoidosis. J Clin Invest 75:1488-1495, 1985
Abdi EA, Nguyen GK, Ludwig RN, Dickout WJ: Pulmonary sarcoidosis following interferon therapy for advanced renal cell carcinoma. Cancer 59:896-900, 1987
Luers C, Sudhop T, Spengler U, Berthold HK: Improvement of sarcoidosis under therapy with interferon-alpha 2b for chronic hepatitis B virus infection. J Hepatol 30:347, 1999
Lauer GM, Walker BD: Hepatitis C virus infection. N Engl J Med 345:41-52, 2001
Malnick SD, Beergabel M, Lurie Y: Treatment of chronic hepatitis C virus infection. Ann Phramacother 34:1156-1164, 2000
Ning Q, Brown D, Parodo J, Cattral M, Gorczynski R, Cole E, Fung L, Ding JW, Liu MF, Rotstein O, Phillips MJ, Levy G: Ribavirin inhibits viral-induced macrophage production of TNF, IL-1, the procoagulant fgl2 prothrombinase and preserves Th1 cytokine production but inhibits Th2 cytokine response. J Immunol 160:3487-3493, 1998
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Tahan, V., Ozseker, F., Guneylioglu, D. et al. CASE REPORT: Sarcoidosis After Use of Interferon for Chronic Hepatitis C: Report of a Case and Review of the Literature. Dig Dis Sci 48, 169–173 (2003). https://doi.org/10.1023/A:1021759120428
Issue Date:
DOI: https://doi.org/10.1023/A:1021759120428